Lyra Therapeutics, Inc. (LYRA)
0.6001
-0.20
(-24.99%)
USD |
OTCM |
Jun 10, 16:00
Lyra Therapeutics Shareholders Equity (Quarterly) : -10.72M for Dec. 31, 2025
Shareholders Equity (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Shareholders Equity (Quarterly) Data
| Date | Value |
|---|---|
| December 31, 2025 | -10.72M |
| September 30, 2025 | -4.328M |
| June 30, 2025 | 1.622M |
| March 31, 2025 | 3.872M |
| December 31, 2024 | 11.59M |
| September 30, 2024 | 20.62M |
| June 30, 2024 | 30.98M |
| March 31, 2024 | 77.50M |
| December 31, 2023 | 89.42M |
| September 30, 2023 | 84.24M |
| June 30, 2023 | 98.58M |
| March 31, 2023 | 66.09M |
| December 31, 2022 | 80.75M |
| Date | Value |
|---|---|
| September 30, 2022 | 93.22M |
| June 30, 2022 | 106.25M |
| March 31, 2022 | 23.26M |
| December 31, 2021 | 34.32M |
| September 30, 2021 | 47.19M |
| June 30, 2021 | 57.50M |
| March 31, 2021 | 67.55M |
| December 31, 2020 | 74.49M |
| September 30, 2020 | 80.91M |
| June 30, 2020 | 86.82M |
| March 31, 2020 | 33.42M |
| December 31, 2019 | 7.328M |
Shareholders' Equity Definition
Shareholder's Equity is a main portion of the balance sheet of a company that measures the net value of a company. The reason for this is because the from an accounting perspective, the balance sheet equation is Shareholder's Equity = Assets - Liabilities. A few examples of shareholder's equity of a company include retained earnings, paid in capital, and preferred stock.
Shareholders Equity (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Shareholders Equity (Quarterly) Benchmarks
| Filana Therapeutics, Inc. | 68.14M |
| CorMedix, Inc. | 437.05M |
| Eloxx Pharmaceuticals, Inc. | -7.584M |
| Cannabis Global, Inc. | -4.772M |
| BioStem Technologies, Inc. | 31.87M |
Shareholders Equity (Quarterly) Related Metrics
| Total Assets (Quarterly) | 36.11M |
| Total Liabilities (Quarterly) | 46.82M |
| Debt to Equity Ratio | -2.824 |
| Current Ratio | 1.709 |
| Net Debt Paydown Yield | 24.82% |